lID Applications in Genetics
11. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler
T (2000) Different transcriptional activity and in vitro TNF-alpha production in psoriasis
patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 114:
1180-1183
12. Lejeune F, Lienard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gerain J, Klaase J,
Kroon B, Vanderveken J, Schmitz P (1995) Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results. J Infus Chemother
5:73-81
13. Li Kam Wa TC, Mansur AH, Britton J, Williams G, Pavord I, Richards K, Campbell DA, Morton N, Holgate ST, Morrison JF (1999) Association between -308 tumour necrosis factor
promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy 29:
1204-1208
14. Lienard D, Eggermont AM, Koops HS, Kroon B, Towse G, Hiemstra S, Schmitz P, Clarke J,
Steinmann G, Rosenkaimer F, Lejeune FJ (1999) Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of intransit melanoma metastases: a multicentre randomized phase II study. Melanoma Res
9:491-502
15. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P,
Malaise M, De Groote D, Louis R, Belaiche J (1998) Tumour necrosis factor (TNF) gene polymorphism influences TNF-a production in lipopolysaccharide (LPS)-stimulated whole
blood cell culture in healthy humans. Clin Exp ImmunoI113:401-406
16. Mabbott NA, Williams A, Farquhar CF, Pasparakis M, Kollias G, Bruce ME (2000) Tumor
necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol 74:3338-3344
17. McGarry F, Walker R, Sturrock R, Field M (1999) The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J RheumatoI26:1110-1116
18. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul
JL, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF (1999) Association of
TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561-568
19. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett -Nedwin J, Pennica D, Goeddel DV, Gray
PW (1985) Human lymphotoxin and tumor necrosis factor genes: structure, homology and
chromosomal localization. Nucleic Acids Res 13:6361-6373
20. Olieman AF, Lienard D, Eggermont AM, Kroon BB, Lejeune FJ, Hoekstra HJ, Koops HS (1999)
Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma,
and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg 134:303-307
21. Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn
W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW (2000) TNF-308A
and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43: 129-134
22. Rosen HR, Lentz JJ, Rose SL, Rabkin J, Corless CL, Taylor K, Chou S (1999) Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation. Transplantation 68:1898-1902
23. Ruddle NH (1999) Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and
development. Immunol Res 19:119-125
24. Skeie GO, Pandey JP, Aarli JA, Gilhus NE (1999) TNFA and TNFB polymorphisms in myasthenia gravis. Arch NeuroI56:457-461
25. Sriskandan S,Moyes D, Lemm G, Cohen J (1996) Lymphotoxin-alpha (TNF-beta) during sepsis. Cytokine. 8:933-937
26. Stuber F, Udalova lA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU,
Nedospasov SA (1996) -308 tumor necrosis factor (TNF) polymorphism is not associated
11. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler
T (2000) Different transcriptional activity and in vitro TNF-alpha production in psoriasis
patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 114:
1180-1183
12. Lejeune F, Lienard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gerain J, Klaase J,
Kroon B, Vanderveken J, Schmitz P (1995) Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results. J Infus Chemother
5:73-81
13. Li Kam Wa TC, Mansur AH, Britton J, Williams G, Pavord I, Richards K, Campbell DA, Morton N, Holgate ST, Morrison JF (1999) Association between -308 tumour necrosis factor
promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy 29:
1204-1208
14. Lienard D, Eggermont AM, Koops HS, Kroon B, Towse G, Hiemstra S, Schmitz P, Clarke J,
Steinmann G, Rosenkaimer F, Lejeune FJ (1999) Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of intransit melanoma metastases: a multicentre randomized phase II study. Melanoma Res
9:491-502
15. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P,
Malaise M, De Groote D, Louis R, Belaiche J (1998) Tumour necrosis factor (TNF) gene polymorphism influences TNF-a production in lipopolysaccharide (LPS)-stimulated whole
blood cell culture in healthy humans. Clin Exp ImmunoI113:401-406
16. Mabbott NA, Williams A, Farquhar CF, Pasparakis M, Kollias G, Bruce ME (2000) Tumor
necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol 74:3338-3344
17. McGarry F, Walker R, Sturrock R, Field M (1999) The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J RheumatoI26:1110-1116
18. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul
JL, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF (1999) Association of
TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561-568
19. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett -Nedwin J, Pennica D, Goeddel DV, Gray
PW (1985) Human lymphotoxin and tumor necrosis factor genes: structure, homology and
chromosomal localization. Nucleic Acids Res 13:6361-6373
20. Olieman AF, Lienard D, Eggermont AM, Kroon BB, Lejeune FJ, Hoekstra HJ, Koops HS (1999)
Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma,
and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg 134:303-307
21. Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn
W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW (2000) TNF-308A
and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43: 129-134
22. Rosen HR, Lentz JJ, Rose SL, Rabkin J, Corless CL, Taylor K, Chou S (1999) Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation. Transplantation 68:1898-1902
23. Ruddle NH (1999) Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and
development. Immunol Res 19:119-125
24. Skeie GO, Pandey JP, Aarli JA, Gilhus NE (1999) TNFA and TNFB polymorphisms in myasthenia gravis. Arch NeuroI56:457-461
25. Sriskandan S,Moyes D, Lemm G, Cohen J (1996) Lymphotoxin-alpha (TNF-beta) during sepsis. Cytokine. 8:933-937
26. Stuber F, Udalova lA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU,
Nedospasov SA (1996) -308 tumor necrosis factor (TNF) polymorphism is not associated